Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gene Therapy00:59

Gene Therapy

25.6K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.6K
iPS Cell Differentiation01:22

iPS Cell Differentiation

2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

371
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
371

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reticulocyte Hemoglobin Equivalent to Diagnose Iron Deficiency Anemia in Acutely Ill Children.

Indian journal of pediatrics·2026
Same author

Prevalence of Absolute and Functional Iron Deficiency in Non-Dialyzed Children with Chronic Kidney Disease.

Indian journal of pediatrics·2025
Same author

Flagellate Dermatosis in a Child.

Indian journal of dermatology·2024
Same author

Profile of Chronic Non-Epilepsy Drug Use in Children with Epilepsy: Single Centre Experience.

Indian pediatrics·2024
Same author

Isolated Decreased Platelets in a Child: Thinking Beyond Immune Thrombocytopenia.

Indian pediatrics·2023
Same author

Pediatric Acute Cardiac Tamponade: A Conundrum Between Tuberculosis and COVID-19.

Indian pediatrics·2023

Related Experiment Video

Updated: Aug 4, 2025

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine
09:54

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine

Published on: November 4, 2018

8.2K

Cell-Based Gene Therapy for b-Thalassemia.

Yajika Arya1, Puneet Kaur Sahi2

  • 1Department of Pediatrics, Maulana Azad Medical College (University of Delhi) and associated Lok Nayak Hospital, New Delhi. Correspondence to: Dr Yajika Arya, Senior Resident, Department of Pediatrics, Lok Nayak Hospital, New Delhi 110 002. yajikachutani95@gmail.com.

Indian Pediatrics
|April 1, 2023
PubMed
Summary
This summary is machine-generated.

The US FDA approved betibeglogene autotemcel (beti-cel), a novel gene therapy for beta-thalassemia, in August 2022. This marks a significant advancement beyond traditional treatments like transfusions and iron chelation.

More Related Videos

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications
08:32

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

Published on: August 9, 2022

3.7K
Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

7.4K

Related Experiment Videos

Last Updated: Aug 4, 2025

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine
09:54

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine

Published on: November 4, 2018

8.2K
CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications
08:32

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

Published on: August 9, 2022

3.7K
Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

7.4K

Area of Science:

  • Hematology
  • Gene Therapy
  • Cellular Therapy

Background:

  • Beta-thalassemia is a serious inherited blood disorder requiring lifelong treatment.
  • Current standard treatments include regular blood transfusions and iron chelation therapy.
  • These treatments manage symptoms but do not offer a cure and can have significant burdens.

Purpose of the Study:

  • To review the recent advancements in beta-thalassemia treatment.
  • To highlight the approval and implications of betibeglogene autotemcel (beti-cel).
  • To discuss novel therapeutic strategies beyond conventional care.

Main Methods:

  • Review of recent clinical trial data and regulatory approvals.
  • Analysis of emerging gene and cell-based therapeutic approaches.
  • Focus on therapies targeting the underlying genetic defect.

Main Results:

  • FDA approval of betibeglogene autotemcel (beti-cel) in August 2022 for adult and pediatric patients.
  • Beti-cel represents the first approved cell-based gene therapy for beta-thalassemia.
  • Emergence of other novel therapeutic strategies is also noted.

Conclusions:

  • Betibeglogene autotemcel (beti-cel) offers a new, potentially curative option for beta-thalassemia.
  • Gene therapy signifies a paradigm shift in managing beta-thalassemia.
  • Continued research into novel therapies promises improved outcomes for patients.